Live Breaking News & Updates on Oncotarget Research Output|Page 1
Stay updated with breaking news from Oncotarget research output. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oncotarget published “Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by ....
Oncotarget published "Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients" which reported that LMNB2 is a chromatin remodeling protein that also plays a role in eukaryotic cell proliferation by organizing the nuclear membrane during mitosis. ....
An increasing number of studies report that proteins do not work in isolation but are part of a complex network of biomolecules, that may differ at various settings or stages of tumor progression. ....
Oncotarget published “TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan” which reported that TAK1 is an ....
Oncotarget published “A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs” which reported ....